Passage Bio, Inc.
PASG
$0.3117
-$0.0145-4.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.07% | 28.66% | 32.97% | 51.33% | 38.10% |
| Total Depreciation and Amortization | -10.90% | -20.77% | -18.51% | -17.59% | -14.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,161.50% | -26.87% | -49.96% | -57.15% | -76.28% |
| Change in Net Operating Assets | -29.37% | 691.61% | -85.29% | -150.74% | -356.06% |
| Cash from Operations | 56.73% | 61.14% | 23.36% | 15.67% | 18.75% |
| Capital Expenditure | -7.69% | -400.00% | -- | -- | 97.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.85% | -33.25% | -92.55% | 18.87% | 363.97% |
| Cash from Investing | 79.97% | -33.33% | -92.50% | 19.01% | 326.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.17% | -- | -4.49% | -- | -25.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.17% | -- | -4.49% | -- | 107.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.49% | 128.77% | -289.58% | 1,325.71% | 57.56% |